Health Care SurveySurvey_AppNCT05605184
Anonymous Survey of Breast Cancer Patients Concerning Their Use of Medical Apps
An observational study of Health Care Survey, run by Technical University of Munich at 1 site in Germany.
Trial summary
Breast cancer patients complete questionnaires concerning their use of medical apps. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Health Care Survey
- What is being tested?
- Survey
- How many people
- 200 participants
- Where
- 1 siteGermany
- Study dates
- 1 Jul 2022to 31 Mar 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Breast cancer patients at TUM Department of Gynecology and Obstetrics
Who may be able to join
- breast cancer patients
- patients who are legally competent and able to understand and follow instructions of the study staff
Who cannot join
- none
Trial locations and contacts
1 site in 1 country.
Germany1 site
Klinikum rechts der Isar, Frauenklinik, Technische Universität München
Munich, Germany, 81675
About this study
Official title: Eine Anonyme Umfrage Bei Brustkrebspatient*innen Zum Thema Nutzerverhalten Von Gesundheits-Apps
Breast cancer patients complete questionnaires concerning their use of medical apps.
Read the detailed description
Breast cancer patients of the department of gynecology at Technical University of Munich and Berlin Charité complete quesionnaires during routine appointments. Intention of the survey is to evaluate the importance of medical apps and the special needs of breast cancer patients. Moreover approaches to improve health care of breast cancer patients are expected to be developed.
- Conditions
- Health Care Survey
- Being tested
- Survey
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
Survey
| Study group | Role | What they receive |
|---|---|---|
| Survey | Breast cancer patients complete questionnaire concerning their use of medical apps. Receives: Other: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
The attitudes of breast cancer patients regarding the use of medical apps: a survey-based study
Evaluation of relative frequency of answers in the questionnaire regarding patient's approach to app-utility
Measured: 6 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Nov 2022
- Study start1 Jul 2022
- Primary completion31 Jan 2023
- Study completion31 Mar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Health Care SurveyStudies of the same condition, open and under way.
- More trials run by Technical University of MunichThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Technical University of Munich
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Heike Jansen, Technical University of Munich
- Investigators
- Heike Jansen, Dr. med., Principal investigator, Technical University of Munich
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05605184
- Sponsor's protocol ID
- Survey_App
- Acronym
- Survey_App
- Status last verified
- Nov 2024
- First submitted
- 12 Aug 2022
- Last updated
- 22 Nov 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Eine Anonyme Umfrage Bei Brustkrebspatient*innen Zum Thema Nutzerverhalten Von Gesundheits-Apps
- ClinicalTrials.gov ID
- NCT05605184
- Acronym / sponsor ID
- Survey_App / Survey_App
- Conditions
- Health Care Survey
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Technical University of MunichUniversity, hospital or other
- Study start
- 1 Jul 2022 (actual)
- Primary completion
- 31 Jan 2023 (actual)
- Study completion
- 31 Mar 2025 (estimated)
- First posted
- 4 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Breast cancer patients complete questionnaires concerning their use of medical apps.
Detailed description
Breast cancer patients of the department of gynecology at Technical University of Munich and Berlin Charité complete quesionnaires during routine appointments. Intention of the survey is to evaluate the importance of medical apps and the special needs of breast cancer patients. Moreover approaches to improve health care of breast cancer patients are expected to be developed.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Survey | – | Other: SurveyBreast cancer patients complete questionnaire concerning their use of medical apps. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Breast cancer patients at TUM Department of Gynecology and Obstetrics
Key inclusion criteria (2 listed)
- breast cancer patients
- patients who are legally competent and able to understand and follow instructions of the study staff
Key exclusion criteria (1 listed)
- none
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveySurvey | Other | Survey |
Primary outcome
The attitudes of breast cancer patients regarding the use of medical apps: a survey-based study
Time frame: 6 Months
Evaluation of relative frequency of answers in the questionnaire regarding patient's approach to app-utility
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Nov 2024.
- Individual participant dataSharing planned: No
Related trials for Health Care Survey
Active, not recruitingPhase 3
PREVENT HPV -Related Cancers Trial
HPV Vaccination, Uptake Vaccination
Enrolling by invitationObservational study
Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils
Arteriovenous Malformation, Gastrointestinal Bleed
RecruitingObservational study
Burnout Syndrome in the Intensive Care Unit Before and During a Palliative Care Trial
Burnout Syndrome
RecruitingObservational study
Addressing Pregnant Women's First Trimester Worries and Information Needs With mHealth Solutions
Pregnancy Trimester, First, Anxiety
RecruitingObservational study
Patients' Refusal to Participate in Surgical Research: Prevalence, Attributed Factors, and How to Overcome
Participation Rate, Patient, Clinical Trials
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Heike Jansen, Dr. med. principal investigator
Technical University of Munich
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Health Care Survey, run by Technical University of Munich at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 22 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The attitudes of breast cancer patients regarding the use of medical apps: a survey-based study (time frame: 6 Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Nov 2024.